Search results

• 2009

  Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: The NNIPPS Study

  NNIPPS Study Group, Bensimon, G., Ludolph, A., Agid, Y., Vidailhet, M., Payan, C., Leigh, P. N., Ludolph, A. C., Dib, M., Lacomblez, L., Burn, D., Landwehrmeyer, B., Asselain, B., Allain, H., Chadwick, D., Perret, J. E., Warlow, C., Ben-Shlomo, Y., Bonnet, A. M. & Fermanian, J. & 31 others, Verny, M., Moore, P., Tranchant, C., Borg, M., McCrone, P., Durif, F., Evans, A., Viallet, F., Verin, M., Deasy, N., Jarosz, J., Al-Sarraj, S., Brown, R., Al-Chalabi, A., Wood, N., Dougherty, A., Murphy, C., Schulz, J. B., Chaudhuri, K. R., Heaney, D., Blain, C., Azam, S., Williams, V., Isaacs, J., Smallman, C., Stanton, B., Dittner, A., Donnellan, C., Secker, D., Langman, A. & Lomax, C., 1 Jan 2009, In: Brain. 132, 1, p. 156-171 16 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Therapeutic Procedure 100%
  • Disease 100%
  • Diagnosis 100%
  • Shy-Drager Syndrome 100%
  • Riluzole 100%
  284 Citations (Scopus)